3B BlackBio Dx Ltd | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

10,199 results for “3B BlackBio Dx Ltd”

Trials

View all 2362 →

Lumax DX / Linox DX Evaluation

38 participants · First posted Dec 7, 2011

Not yet recruiting

UNITY DX Cornea Study

110 participants · First posted Aug 17, 2026

A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants

38 participants · First posted Mar 21, 2014

Drugs

View all 1583 →

3B-201

3B-301

3B-401

Organizations

View all 4089 →

3B Pharmaceuticals GmbH

Germany

CLOUD DX, INC.

United States

HIKARI DX, INC.

United States

News

View all 2165 →

Avacta Completes Transition to Pure-Play Therapeutics with £2.2M Coris Sale

PharmaEssentia Launches Phase 3b Trial of Ropeginterferon Alfa-2b for Polycythemia Vera with Accelerated Dosing

QIAGEN's QIAstat-Dx Meningitis/Encephalitis Panel Receives FDA Clearance for Rapid Diagnostics

Page 1 of 1020